For medium-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 4D-Nucleofector® 96-well Unit
Naïve Kupffer cells derived from human liver tissue. 0.2 million cells per vial
Naïve Kupffer cells derived from human liver tissue. 0.5 million cells per vial.
For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit
For medium-throughput transfection of cell lines, e.g. Jurkat or MCF-7, when working with the 4D-Nucleofector® 96-well Unit
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
For measuring all sorts of glow luminescence. Provides results for MycoAlert® Mycoplasma Detection Assays immediately.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
References - X-Vivo™Overview of relevant references
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
Serum-free Media FFM Part Codes2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.